Cannabidiol (CBD) is a nonpsychoactive component ... investigators say that it is usually better tolerated than antipsychotic medications. Investigators plan to begin trial recruitment in April.
The cannabis-derived compound cannabidiol (CBD) is gaining traction as a treatment for a broad range of conditions, but it's ...